Used in cancer research to target TMEFF1 (Tomoregulin-1), a protein overexpressed in certain tumors such as glioblastoma and prostate cancer. This reference antibody serves as a critical tool for detecting, quantifying, and localizing TMEFF1 in tissue samples, enabling studies on its role in tumor progression and cell signaling. It supports immunohistochemistry, flow cytometry, and Western blot applications in preclinical studies. Due to its high specificity, it is also used in the development and validation of diagnostic assays and potential therapeutic antibodies. Its patent-protected status makes it valuable for proprietary research and biopharmaceutical development targeting TMEFF1-expressing cancers.